Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers and dealmakers "reprice risk," according to a midyear outlook report | The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers and dealmakers "reprice risk," according to a midyear outlook report from PwC.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, payers and other industry players…

Hospital dealmaking remained hot during the second quarter of 2026, extending a merger and acquisition rebound that has lately…

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, payers and other industry players…

The number of insurers offering plans on the Affordable Care Act's marketplaces declined between 2025 and 2026, with more payers…

Healthcare costs continue to rise, making effective payer-provider collaboration more important than ever. Download this free…

The first quarter of 2026 brought plenty of opportunity for HCA Healthcare to stock up on outpatient facilities, with management…